✦ LIBER ✦

UP-01.052 Outcome of Treatment of High-Risk, Non Muscle-Invasive Bladder Cancer with Mitomycin Hyperthermia with a Minimum Follow-Up of Two Years

✍ Scribed by S. Mukhtar; H. Al-Najjar; J. Durrant; A. Connor; C. Corbishley; M. Bailey

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

UP.90: Clinical Outcome of Primary Conse

✍ M. Fernández; M. Schultz; A. Krebs; H. Bermudez; G. Larach; R. Lyng; P. Poblete; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Two-year follow-up of the phase II marke

✍ Kees Hendricksen; Antoine G. van der Heijden; Erik B. Cornel; Henk Vergunst; The 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 286 KB

1109 Challenging the gold standard: A co

✍ Nair, R.; Pai, A.; Kaul, A.; Ayres, B.; Bailey, M.; Perry, M.; Issa, R. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 109 KB

1105 The efficacy and safety of mitomyci

✍ Pai, A.; Ayres, B.E.; Nair, R.; Corbishley, C.; Naji, Z.; Bailey, M.; Perry, M.J 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 111 KB

MP-19.14: Three year follow-up of a mult

✍ M.G. Friedrich; U. Pichlmeier; H. Schwaibold; H. Huland; S. Conrad 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Intravesical mitomycin C combined with l

✍ Maffezzini, Massimo; Campodonico, Fabio; Canepa, Giorgio; Manuputty, Egi Edward; 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 260 KB